Europe/India/Near East USA Asia
Bachem AG Bachem Americas, Inc. Bachem Japan K.K.
Hauptstrasse 144 3132 Kashiwa Street AREA Shinagawa, 13F
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA Tokyo 108-0075 - Japan
Tel +41 58 595 2021 Tel +1 888 422 2436 Tel +81 3 4405 3141
Fax +41 58 595 2040 Tel +1 888 4BACHEM Email
Email Fax +1 310 539 9428  


Bachem and ILS extend their collaboration in Japan by an Exclusive Agency Agreement

07. Sep 2015

Bubendorf/Basel, Switzerland and Ibaraki, Japan, September 7th, 2015 – Bachem (SIX: BANB) and ILS announce today that they will strengthen their co-marketing efforts in Japan. The two companies have been establishing a close collaboration for more than a decade, already. Based on a Sales and Marketing agreement which was signed in 2012, ILS is providing Bachem manufactured Active Pharmaceutical Ingredients (APIs) to Japanese customers. In the course of the acquisition of American Peptide Company, Inc. (APC), based in California USA, and its transfer from ILS to Bachem, both companies underlined their intentions to extend the current business relations. Under the agreement reached, ILS will be the Exclusive Agent for Japan for all peptide-based products of the Bachem Group; this applies to non-GMP research chemicals as well as for cGMP grade APIs. In addition, ILS will register Drug Master Files in Japan for APIs manufactured by Bachem.

Press Release